Drug
Ab801
Ab801: highest development phase Phase 1, developed by Arcus Biosciences. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB801 NCT06120075 | Phase 1 | Advanced Cancer |
| AB801 NCT06004921 | Phase 1 | Cancer |
Latest
No recent events.
Follow Ab801 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.